Microfluidic Screening with Encoded Effectors
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current drug development methods face challenges in accurately testing chemical substances' effects on cellular and biological components due to limitations in customizing reagent concentrations and detecting biological responses, leading to high false positives and negatives, especially in complex environments.
Innovation Solution
The use of microfluidic systems with encoded effectors allows for precise addition of reagents at specified concentrations and non-destructive monitoring of biological samples, enabling high-throughput assays that can detect functional activities and synergistic effects of multiple compounds, even in complex environments, using DNA barcodes and photocleavable linkers for controlled effector release.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If traditional high-throughput screening methods are used, then large numbers of compounds can be screened, but false positives and negatives increase due to inability to customize reagent concentrations
Solution Approach 1:
The system divides the screening process into individual microfluidic channels, each handling a single compound-library combination. This segmentation allows independent optimization of reagent concentrations for each channel while maintaining high throughput across the entire array, thereby reducing false positives and negatives caused by uniform dosing limitations.
Solution Approach 2:
The microfluidic system enables dynamic adjustment of reagent concentrations and flow rates for each individual channel. By changing physical parameters (flow velocity, channel dimensions) and chemical parameters (reagent concentrations, incubation times) independently for each assay, the system maintains screening throughput while improving detection accuracy.
2Loss of information
If encoded effectors with DNA barcodes are used, then detailed information about compound interactions can be obtained, but system complexity increases
Solution Approach 1:
The system uses DNA barcodes as information carriers that copy and store the identity of each effector. Instead of complex physical tracking systems, simple DNA sequence copying provides robust identification and tracking of effectors through multiple microfluidic operations, reducing system complexity while maximizing information retention.
Solution Approach 2:
DNA barcodes serve as intermediary molecules that mediate between the physical effector molecules and the digital information systems. This intermediary layer simplifies the interface between biological samples and data processing, allowing detailed tracking of compound interactions without requiring direct complex communication between all system components.
3Productivity
If uniform dosing of effectors is applied across a library screen, then screening speed is maintained, but false positives increase due to low potency but highly-loaded effectors
Solution Approach 1:
The microfluidic system implements local quality control by allowing different effector concentrations in different channels based on specific assay requirements. Each channel can be optimized with the appropriate dose for its particular target and effector, preventing false positives from uniformly dosed low-potency compounds while maintaining overall screening speed through parallel processing.
4Measurement precision
If physical sorting of effectors is performed to deconvolute hits, then accurate identification of active compounds is achieved, but time and operational complexity increase
Solution Approach 1:
The system replaces mechanical physical sorting operations with DNA-based information encoding and sequencing. Instead of physically manipulating and sorting effector molecules through complex mechanical systems, the DNA barcode information is extracted and sequenced using streamlined molecular biology techniques, dramatically reducing deconvolution time while maintaining high identification accuracy.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly reduces false positives and negatives, enables fast and iterative screening of chemically diverse compounds, and provides detailed information on compound interactions, improving drug discovery efficiency and reducing operational costs.
Implementation Method 1
the encoded effector is bound to the scaffold by a photocleavable linker
Data Source
AI summary
Provided are methods and systems useful for screening large libraries of effector molecules. Such methods and systems are particularly useful in microfluidic systems and devices. The methods and systems provided herein utilize encoded effectors to screen large libraries of effectors.